Get the Stockscreener App
0.9763
2.38%
-0.0237
INVO Bioscience Inc Stock (INVO) Forecast
The INVO Bioscience Inc (INVO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5578, representing a -42.86% decrease from the current price of $0.9763. The highest analyst price target is $1.0494, and the lowest is $0.0662.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INVO Price Target
Average 0.9761
(-0.02% Downside)
Is INVO Bioscience Inc (INVO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.52 | Neutral |
| STOCH(9,6) | 59.86 | Neutral |
| STOCHRSI(14) | 30.44 | Neutral |
| MACD(12,26) | -0.00651 | Buy |
| ADX(14) | 33.00 | Buy |
| William %R | -67.62 | Neutral |
| CCI(14) | 22.01 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0028
Sell
|
1.0236
Sell
|
| MA20 |
1.0307
Sell
|
1.0278
Sell
|
| MA50 |
1.0392
Sell
|
1.0425
Sell
|
| MA100 |
1.0587
Sell
|
1.0717
Sell
|
| MA200 |
1.1958
Sell
|
1.0296
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, INVO could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on INVO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.52 indicates that INVO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 59.86 indicates that INVO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.44 indicates that INVO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 33 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 22.01 indicates that INVO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term INVO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about INVO Bioscience Inc financial reports and earnings history, INVO Bioscience Inc (INVO) stock could reach $3.5045 by 2030, $11.94 by 2040 and $22.42 by 2050. See the projected annual prices until 2050 of the INVO Bioscience Inc stock below:
- INVO Bioscience Inc (INVO) is expected to reach an average price of $1.5587 in 2035, with a high prediction of $1.6575 and a low estimate of $1.4599. This indicates an $59.65% rise from the last recorded price of $0.9763.
- INVO Bioscience Inc (INVO) stock is projected to chart a bullish course in 2040, with an average price target of $12.02, representing an $1,132% surge from its current level. The forecast ranges from a conservative $12.03 to a sky-high $11.94.
- Our analysts predict INVO Bioscience Inc (INVO) to jump 624.21% by 2045, soaring from $7.1014 to an average price of $7.0704, potentially reaching $7.1617. While $7.1014 is the low estimate, the potential upside is significant.
- INVO Bioscience Inc (INVO) stock is expected to climb by 2050, reaching an average of $21.65, a $2,118% jump from its current level. However, a wide range of estimates exists, with high and low targets of $22.42 and $22.32, respectively, highlighting the market's uncertainty.
INVO Bioscience Inc Stock (INVO) Year by Year Forecast
INVO Bioscience Inc Stock (INVO) Price Forecast for 2024
Our forecast for INVO stock price in 2024 now indicates an average price target of $1.7653 with a high forecast of $3.50 and a low forecast of $0.0306. The average prediction reflects an increase of +80.82% from the last recorded price of $0.9763.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $0.5094 | $0.0662 | $1.0494 | -47.82% |
| July, 2024 | $0.7875 | $0.0306 | $0.9575 | -19.34% |
| August, 2024 | $1.19 | $0.6588 | $1.9364 | +21.89% |
| September, 2024 | $0.9525 | $0.4525 | $1.3457 | -2.43% |
| October, 2024 | $0.5307 | $0.3207 | $1.0438 | -45.64% |
| November, 2024 | $0.2732 | $0.118 | $0.7004 | -72.02% |
| December, 2024 | $0.7057 | $0.0357 | $1.0557 | -27.72% |
INVO Bioscience Inc Stock (INVO) Price Forecast for 2025
INVO Bioscience Inc Stock (INVO) is expected to reach an average price of $0.8663 in 2025, with a high prediction of $1.7167 and a low estimate of $0.0158. This indicates an -11.27% fall from the last recorded price of $0.9763.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.1838 | $0.0638 | $1.117 | -81.17% |
| February, 2025 | $0.1037 | $0.1393 | $0.2975 | -89.38% |
| March, 2025 | $0.3389 | $0.0789 | $1.0518 | -65.29% |
| April, 2025 | $0.267 | $0.0158 | $0.8751 | -72.65% |
| May, 2025 | $0.1695 | $0.024 | $0.7026 | -82.64% |
| June, 2025 | $0.128 | $0.1551 | $0.2367 | -86.89% |
| July, 2025 | $0.8298 | $0.2423 | $0.4398 | -15.00% |
| August, 2025 | $1.2323 | $1.1042 | $0.9486 | +26.23% |
| September, 2025 | $1.6848 | $1.5817 | $1.6048 | +72.57% |
| October, 2025 | $1.7227 | $1.6692 | $1.7167 | +76.45% |
| November, 2025 | $1.4542 | $1.4797 | $1.582 | +48.95% |
| December, 2025 | $1.398 | $1.4029 | $1.3417 | +43.20% |
INVO Bioscience Inc Stock (INVO) Price Forecast for 2026
The predicted value for INVO Bioscience Inc (INVO) in 2026 is set at an average of $1.3213. Estimates vary from a peak of $1.6135 to a trough of $1.0292, indicating an +35.34% surge from the present price of $0.9763.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.2266 | $1.0292 | $1.2428 | +25.64% |
| February, 2026 | $1.031 | $1.0767 | $0.9879 | +5.61% |
| March, 2026 | $1.0485 | $1.1254 | $1.0046 | +7.40% |
| April, 2026 | $1.5004 | $1.1303 | $1.2904 | +53.68% |
| May, 2026 | $1.5384 | $1.6401 | $1.6135 | +57.57% |
| June, 2026 | $1.2757 | $1.4148 | $1.4822 | +30.66% |
| July, 2026 | $1.3071 | $1.3029 | $1.2642 | +33.89% |
| August, 2026 | $1.2347 | $1.2747 | $1.2322 | +26.47% |
| September, 2026 | $1.3965 | $1.2441 | $1.3066 | +43.04% |
| October, 2026 | $1.394 | $1.3944 | $1.3128 | +42.78% |
| November, 2026 | $1.4616 | $1.4476 | $1.4116 | +49.70% |
| December, 2026 | $1.3874 | $1.3924 | $1.4319 | +42.11% |
INVO Bioscience Inc Stock (INVO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for INVO Bioscience Inc (INVO) is $2.8406, with a high forecast of $5.6621 and a low forecast of $0.0191. This indicates an +190.96% increase from the last price of $0.9763.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1491 | $0.0691 | $5.6621 | -84.73% |
| February, 2027 | $0.0716 | $0.0397 | $0.2716 | -92.67% |
| March, 2027 | $0.5603 | $0.0978 | $0.4994 | -42.61% |
| April, 2027 | $0.0378 | $0.0234 | $1.7366 | -96.13% |
| May, 2027 | $0.8247 | $0.0191 | $1.2291 | -15.52% |
| June, 2027 | $0.0829 | $0.0471 | $1.1804 | -91.51% |
| July, 2027 | $0.0346 | $0.0441 | $0.3185 | -96.46% |
| August, 2027 | $0.1021 | $0.0534 | $0.101 | -89.54% |
| September, 2027 | $0.266 | $0.0648 | $0.346 | -72.75% |
| October, 2027 | $0.0265 | $0.0602 | $0.3273 | -97.28% |
| November, 2027 | $0.1811 | $0.0555 | $2.6498 | -81.45% |
| December, 2027 | $2.8562 | $0.1467 | $2.7262 | +192.56% |
INVO Bioscience Inc Stock (INVO) Price Forecast for 2028
In 2028, INVO Bioscience Inc (INVO) is projected to reach an average price of $2.7492, with a high projection of $3.1098 and a low estimate of $2.3887. This indicates an +181.60% rise from the last price of $0.9763.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.0912 | $3.1912 | $3.1087 | +216.63% |
| February, 2028 | $2.6962 | $2.9562 | $3.0587 | +176.16% |
| March, 2028 | $2.2699 | $2.4099 | $2.5649 | +132.50% |
| April, 2028 | $2.4449 | $2.3887 | $2.2674 | +150.43% |
| May, 2028 | $2.7886 | $2.5524 | $2.6586 | +185.63% |
| June, 2028 | $2.9836 | $2.8261 | $2.8436 | +205.60% |
| July, 2028 | $2.4886 | $3.1586 | $3.0711 | +154.90% |
| August, 2028 | $2.9323 | $2.6861 | $2.9023 | +200.35% |
| September, 2028 | $3.1573 | $3.2086 | $3.1098 | +223.39% |
| October, 2028 | $2.6523 | $2.4835 | $2.6596 | +171.67% |
| November, 2028 | $2.646 | $2.5097 | $2.426 | +171.02% |
| December, 2028 | $2.681 | $2.7048 | $2.5923 | +174.61% |
INVO Bioscience Inc Stock (INVO) Price Forecast for 2029
The 2029 price forecast for INVO Bioscience Inc Stock (INVO) is $3.4522 on average, with a high prediction of $4.2246 and a low estimate of $2.6797. This represents an +253.60% increase from the previous price of $0.9763.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.9547 | $2.6797 | $2.8372 | +202.64% |
| February, 2029 | $3.5397 | $3.0022 | $3.1497 | +262.56% |
| March, 2029 | $3.8797 | $3.7959 | $3.6272 | +297.39% |
| April, 2029 | $4.2697 | $4.2134 | $4.1897 | +337.33% |
| May, 2029 | $4.2294 | $4.2384 | $4.2246 | +333.21% |
| June, 2029 | $3.8984 | $3.9283 | $4.073 | +299.30% |
| July, 2029 | $3.7682 | $3.8159 | $3.7571 | +285.96% |
| August, 2029 | $3.5302 | $3.3483 | $3.6721 | +261.59% |
| September, 2029 | $3.2721 | $3.3221 | $3.2758 | +235.15% |
| October, 2029 | $3.1358 | $3.2932 | $3.2208 | +221.19% |
| November, 2029 | $3.6008 | $3.2845 | $3.3908 | +268.82% |
| December, 2029 | $3.5762 | $3.6779 | $3.667 | +266.31% |
INVO Bioscience Inc Stock (INVO) Price Forecast for 2030
INVO Bioscience Inc Stock (INVO) is expected to reach an average price of $2.35 in 2030, with a high forecast of $4.1243 and a low forecast of $0.5757. This signifies an +140.70% surge from the last price of $0.9763.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.2995 | $3.3195 | $3.5045 | +237.96% |
| February, 2030 | $3.2044 | $3.2044 | $3.2083 | +228.21% |
| March, 2030 | $3.0694 | $3.1094 | $3.1138 | +214.39% |
| April, 2030 | $3.1084 | $3.0632 | $2.9977 | +218.39% |
| May, 2030 | $3.088 | $3.0884 | $3.0632 | +216.30% |
| June, 2030 | $3.0931 | $3.1131 | $3.0569 | +216.82% |
| July, 2030 | $2.9409 | $2.9459 | $3.0479 | +201.22% |
| August, 2030 | $1.3418 | $0.5757 | $4.1243 | +37.44% |
| September, 2030 | $1.3568 | $1.3878 | $1.2606 | +38.98% |
| October, 2030 | $1.9105 | $1.5106 | $1.8496 | +95.69% |
| November, 2030 | $1.3255 | $1.3268 | $1.9181 | +35.77% |
| December, 2030 | $0.4005 | $0.7805 | $1.1722 | -58.98% |
0.60%
0.02%
Cap:
|
Volume (24h):